|1.||Janckila, Anthony J: 23 articles (06/2014 - 06/2002)|
|2.||Chao, Tsu-Yi: 17 articles (12/2015 - 05/2003)|
|3.||Yam, Lung T: 17 articles (09/2011 - 06/2002)|
|4.||Halleen, Jussi M: 13 articles (11/2013 - 06/2002)|
|5.||Terpos, Evangelos: 12 articles (01/2014 - 01/2003)|
|6.||Andersson, Göran: 10 articles (11/2015 - 09/2004)|
|7.||Wu, Yi-Ying: 9 articles (01/2015 - 04/2008)|
|8.||Väänänen, H Kalervo: 8 articles (05/2008 - 10/2003)|
|9.||Lee, Su-Huei: 7 articles (12/2015 - 07/2004)|
|10.||Ku, Chih-Hung: 7 articles (05/2011 - 01/2005)|
01/01/2014 - "In our study, gene knockout mice, RNA interference, western blot, quantitative real-time PCR, tartrate-resistant acid phosphatase (TRAP) staining, pit formation assay, histomorphometry and measurement of serum parameters were employed to investigate the role of TRPV6 in bone homeostasis, osteoclastogenesis and bone resorption. "
01/01/2010 - "Tartrate-resistant acid phosphatase 5b, a good bone resorption marker, was significantly decreased at week 2 of the study. "
01/01/2001 - "After 12 weeks histologic studies of treated animals revealed that osteoclasts were positive for tartrate-resistant acid phosphatase but showed markedly abnormal ultrastructure which prevented successful bone resorption. "
07/31/1992 - "This provides opportunities to develop the use of Type 5 acid phosphatase as a reporter of pathophysiological events and an essential, though not sufficient, role in bone resorption by osteoclasts has been established by such studies."
07/01/2015 - "In terms of bone resorption markers, the plasma level of tartrate-resistant acid phosphatase isoform 5b (TRAP5b) rose significantly, commencing 1 week prepartum, and was maintained at this level to a few days postpartum. "
|2.||Neoplasm Metastasis (Metastasis)
01/01/2010 - "We tested the hypothesis that baseline serum TRACP 5b activity and its interval change are potential prognostic markers of survival in BC patients with bone metastasis. "
05/01/2009 - "We also found an unusually low TRACP-5b/RANKL ratio for patients who have or later developed metastasis. "
11/01/2006 - "Of the three novel markers tested, only TRACP 5b proved to be predictive of survival in PC with bone metastases. "
07/01/2006 - "The combination of TRACP with ICTP did not significantly improve the detection of bone metastases over tALP."
07/01/2006 - "Serum TRACP 5b, ICTP and tALP exhibited equal performances in the detection of bone metastases. "
|3.||Breast Neoplasms (Breast Cancer)
12/01/2015 - "Association of Tartrate-Resistant Acid Phosphatase-Expressed Macrophages and Metastatic Breast Cancer Progression."
11/15/2015 - "The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells."
01/01/2011 - "The TRAcP 5b concentration was significantly higher in breast cancer patients compared to healthy probands. "
02/01/2007 - "Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP)."
03/01/2003 - "These results suggest that serum TRACP 5b activity may be a useful marker for the early detection of the spreading of breast cancer cells to bone."
01/01/2014 - "Osteoclasts in tumor sections were also stained for tartrate-resistant acid phosphatase (TRAP). "
01/01/2011 - "In vitro differentiation of SPARC KO osteoclasts indicated accelerated progenitor expansion and formation of tartrate-resistant acid phosphatase-positive osteoclast-like cells with increased resorptive capacity, a mechanism resulting in enhanced tumor-induced bone loss in vivo. "
10/01/2009 - "The tumors were resected, and stained with TUNEL stain, tartrate-resistant acid phosphatase (TRAP) stain to detect tumor-associated macrophages, and immunohistochemical stains for CD4 and CD8. "
01/01/2009 - "Coculture of tumor cells with bone marrow significantly increased activation of bone marrow-derived osteoclasts as assessed by tartrate-resistant acid phosphatase staining (156 +/- 10.8 osteoclasts per well) compared to bone marrow culture alone (91.67 +/- 4.7, P = .005). "
12/01/2008 - "In conclusion, tumor-infiltrating osteoclasts are frequently found in OS and increased serum TRACP 5b levels and the presence of active osteoclast at primary sites were positively associated with tumor aggressiveness."
|5.||Hairy Cell Leukemia
03/01/2005 - "The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia."
06/01/2004 - "Tartrate resistant acid phosphatase (TRAP) staining and scanning electron microscopy of peripheral blood lymphocytes indicated hairy cell leukemia. "
11/01/2001 - "TRACP 5b is considered to be a marker of the osteoclasts and 5a is found in Gaucher's cells, or in the leukocytes of patients with hairy cell leukemia."
09/01/1997 - "The demonstration of tartrate-resistant acid phosphatase (TRAP) activity has long been a cornerstone in the diagnosis of hairy cell leukemia (HCL). "
12/01/1993 - "Tartrate-resistant acid phosphatase (TRAP) became known as the characteristic, albeit not specific, marker enzyme for hairy cell leukemia (HCL). "
|5.||tartrate-resistant acid phosphatase (TSAP)
|6.||Biological Markers (Surrogate Marker)
|7.||Hydroxyproline (4 Hydroxyproline)
|8.||ruberythric acid (AlP)
|9.||Collagen Type I (Type I Collagen)
|1.||Renal Dialysis (Hemodialysis)